VERTEX PHARMACEUTICALS INC / MA Deferred Income Tax 2010-2025 | VRTX
Beta
What is deferred income tax?
Deferred income tax represents the difference between income tax expense recognized on the income statement and the actual tax liability paid.
What is VERTEX PHARMACEUTICALS INC / MA's current deferred income tax?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual deferred income tax for 2025 was $-510.8M, a 46.44% decline from 2024. VERTEX PHARMACEUTICALS INC / MA deferred income tax for the quarter ending September 30, 2020 was $0.
What was VERTEX PHARMACEUTICALS INC / MA's deferred income tax in 2024?
VERTEX PHARMACEUTICALS INC / MA annual deferred income tax for 2024 was $-348.8M, a 34.99% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's deferred income tax in 2023?
VERTEX PHARMACEUTICALS INC / MA annual deferred income tax for 2023 was $-536.5M, a 94.45% decline from 2022.
Deferred Income Tax History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$277.3M
→
FY2025
$-510.8M
10111213141516171819202122232425
5 years selected
Deferred Income Tax History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-510.8M | -46.4% | 10-K |
| FY2024 | $-348.8M | +35.0% | 10-K |
| FY2023 | $-536.5M | -94.5% | 10-K |
| FY2022 | $-275.9M | -78.5% | 10-K |
| FY2021 | $-154.6M | -155.8% | 10-K |
| FY2020 | $277.3M | +65.7% | 10-K |
| FY2019 | $167.4M | +111.1% | 10-K |
| FY2018 | $-1.51B | -1086.2% | 10-K |
| FY2017 | $-127.5M | -856.3% | 10-K |
| FY2016 | $16.9M | +5556.4% | 10-K |
| FY2015 | $298,000 | +5.7% | 10-K |
| FY2014 | $282,000 | +100.2% | 10-K |
| FY2013 | $-127.6M | - | 10-K |
| FY2012 | $0 | +100.0% | 10-K |
| FY2011 | $-11.1M | - | 10-K |
| FY2010 | $0 | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →